|
2023
|
Invention
|
Compositions and methods to increase the systemic bioavailability of a polypeptide therapeutic ag... |
|
2021
|
Invention
|
Inhalable powder formulations of alginate oligomers. A method of preparing spray dried particles ... |
|
2020
|
Invention
|
Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which... |
|
2019
|
Invention
|
Method for the qualitative and quantitative detection of alginate oligomers in body fluids. Quali... |
|
|
Invention
|
Method for the qualitative and quantitative detection of alginate oligomers in body fluids. The p... |
|
|
Invention
|
Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers... |
|
2018
|
Invention
|
A companion diagnostic method for use in the treatment of cystic fibrosis with alginate oligomers... |
|
2017
|
Invention
|
Use of alginate oligomers in combating biofilms. The invention provides a method for combating bi... |
|
|
Invention
|
Bacitracin-alginate oligomer conjugates.
A bacitracin-alginate oligomer conjugate including a ba... |
|
|
Invention
|
Polymyxin-alginate oligomer conjugates.
A polymyxin-alginate oligomer conjugate including a poly... |
|
|
Invention
|
Bacitracin-alginate oligomer conjugates. The invention provides abacitracin-alginate oligomer con... |
|
|
Invention
|
Polymyxin-alginate oligomer conjugates. The invention provides apolymyxin-alginate oligomer conju... |
|
2016
|
Invention
|
Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal trac... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cystic fibrosis, pulmonary diseases, acute and c... |
|
|
G/S
|
Pharmaceutical, medical and veterinary preparations. |
|
|
Invention
|
Use of aliginate oligomers and cftr modulators in treatment of conditions associated with cftr dy... |
|
|
Invention
|
Use of alginate oligomers and cftr modulators in the treatment of conditions associated with cftr... |
|
2015
|
Invention
|
Inhalable powder formulations of alginate oligomers.
Spray dried particles are for inhalation. T... |
|
|
Invention
|
Inhalable powder formulations of alginate oligomers. The invention provides spray dried particles... |
|
|
Invention
|
Alginate oligomers for use in overcoming multidrug resistance in bacteria. The invention provides... |
|
|
Invention
|
Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated wit... |
|
2014
|
Invention
|
Use of alginate oligomers as blood anticoagulants. The disclosure relates to an alginate oligomer... |
|
|
Invention
|
Use of alginate oligomers as blood anticoagulants. The invention provides an alginate oligomer of... |
|
2012
|
Invention
|
Use of alginate oligomers to enhance the effects of antifungal agents.
The disclosure relates to... |
|
|
Invention
|
Use of alginate oligomers to enhance the effects of antifungal agents. Use of alginate oligomers ... |
|
2010
|
Invention
|
Treatment of acinetobacter with alginate oligomers and antibiotics. Acinetobacter contamination o... |
|
|
Invention
|
Alginate oligomers for the inhibition of microbial adherence to surfaces. The present invention p... |
|
|
Invention
|
Treatment of acinetobacter with alginate oligomers and antibiotics. The invention provides a meth... |
|
|
Invention
|
Anti-microbial alginate oligomers. The present invention provides a method for inhibiting the via... |
